• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Grindr Appoints Veteran Public Company CFO and Audit Committee Chair Chad Cohen to Board of Directors

    6/3/25 4:05:00 PM ET
    $ADPT
    $GRND
    $TRUP
    $VCSA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Computer Software: Programming Data Processing
    Technology
    Get the next $ADPT alert in real time by email

    Cohen to serve as Chair of the Audit Committee

    Grindr Inc. (NYSE:GRND), the Global Gayborhood in Your Pocket™, today announced the appointment of Chad Cohen, former Chief Financial Officer of Zillow Group Inc. (NASDAQ:Z) and Adaptive Biotechnologies Corp. (NASDAQ:ADPT) and Founding Partner of Scala Advisors, LLC, to Grindr's Board of Directors as of June 3, 2025. Cohen was also appointed to serve as the Chair of Grindr's Audit Committee.

    A seasoned public company finance executive and board member, Cohen has helped grow several multi-billion dollar technology companies, including multiple leading consumer Internet brands. Prior to his current role, Cohen served as the Chief Financial Officer and Chief Operating Officer for Capella Space, a satellite-based earth observation company; as well as the Chief Financial Officer at Adaptive Biotechnologies, an immune-driven medicine company; and Zillow Group, a leading real-estate marketplace company. During his tenure, Cohen played a pivotal role in leading both Zillow and Adaptive Biotechnologies through their IPOs and scaling both companies through periods of hypergrowth.

    Additionally, Cohen served as a Board Director and Chair of the audit committee for Vacasa, Inc. (NASDAQ:VCSA), a vacation rental management platform, and for Trupanion, Inc. (NASDAQ:TRUP), a pet insurance company. Cohen was also an Operating Partner at Cota Capital, Assistant Controller at Ticketmaster Entertainment, VP and Assistant Controller at Countrywide Bank, and Supervising Senior Auditor at Ernst & Young. He began his career as a Financial Planning Analyst at Novellus Systems. Today, Cohen serves as Founding Partner and CEO at Scala Advisors, LLC, where he leverages his expertise to advise public and private companies on finance, business operations, and investor relations initiatives. With Cohen's appointment, Director Gary Horowitz stepped down from Grindr's Board.

    "We are pleased to welcome Chad to Grindr's Board of Directors," said Grindr CEO George Arison. "His broad experience and deep expertise in helping grow successful public companies will be an invaluable asset to Grindr's Board. I look forward to collaborating with Chad as we continue to expand Grindr's capabilities as the Global Gayborhood in Your Pocket. I also want to thank both Gary Horowitz for his dedicated service to Grindr and Nathan Richardson for serving as our Audit Committee Chair during our first three years as a public company, and I'm happy that Nathan is continuing on the Board and the Audit Committee."

    "Grindr has established itself as the premier social platform and market leader in dating apps for the gay community. Its outstanding business performance and strong financial profile is a testament to its leading market position, and I am thrilled to be joining the Board of Directors," said Cohen. "I look forward to providing my expertise and support to George and the management team to advance Grindr's mission."

    About Grindr

    With more than 14.5 million average monthly active users, Grindr has grown to become the Global Gayborhood in Your Pocket™, on a mission to make a world where the lives of our global community are free, equal, and just. Available in 190 countries and territories, Grindr is often the primary way for its users to connect, express themselves, and discover the world around them. Since 2015, Grindr for Equality has advanced human rights, health, and safety for millions of LGBTQ+ people in partnership with organizations in every region of the world. Grindr has offices in West Hollywood, the Bay Area, Chicago, and New York. The Grindr app is available on the App Store and Google Play.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250603135210/en/

    Investors:

    IR@grindr.com

    Media:

    Press@grindr.com

    Get the next $ADPT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADPT
    $GRND
    $TRUP
    $VCSA

    CompanyDatePrice TargetRatingAnalyst
    Adaptive Biotechnologies Corporation
    $ADPT
    12/2/2025$21.00Equal-Weight
    Morgan Stanley
    Adaptive Biotechnologies Corporation
    $ADPT
    9/30/2025$20.00Buy
    Guggenheim
    Zillow Group Inc.
    $Z
    9/17/2025$105.00Mkt Perform → Outperform
    Bernstein
    Trupanion Inc.
    $TRUP
    8/13/2025$47.00Neutral
    Cantor Fitzgerald
    Grindr Inc.
    $GRND
    6/30/2025$27.00Mkt Outperform
    Citizens JMP
    Adaptive Biotechnologies Corporation
    $ADPT
    6/18/2025$15.00Buy
    Craig Hallum
    Zillow Group Inc.
    $Z
    3/28/2025$80.00Mkt Perform
    Keefe Bruyette
    Adaptive Biotechnologies Corporation
    $ADPT
    3/21/2025$9.00Neutral → Buy
    Goldman
    More analyst ratings

    $ADPT
    $GRND
    $TRUP
    $VCSA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results

    SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 was an outstanding year for Adaptive, marked by strong execution and meaningful progress across the business," said Chad Robins, chief executive officer and co-founder of Adaptive Biotechnologies. "We delivered 46% revenue growth and achieved profitability in our MRD business, while advancing our Immune Medici

    2/5/26 4:05:00 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Zillow's January Market Report shows improving affordability for home buyers

    U.S. home values have fallen for six consecutive months, according to the Zillow Home Value Index SEATTLE, Feb. 4, 2026 /PRNewswire/ -- U.S. home values fell on a monthly basis for the sixth consecutive month in January, according to the Zillow® Home Value Index. This trend mirrors last year, when home values fell each month from August 2024 to February 2025. The monthly mortgage payment on a typical U.S. home is now 8.4% less expensive than a year ago, driven down primarily by lower mortgage rates. New listings and the early read on sales both fell in January compared to last

    2/4/26 8:00:00 AM ET
    $Z
    $ZG
    Real Estate

    Boston and Seattle are playing for a trophy, and a home value boost might follow for the winner

    Zillow data shows championship markets usually beat national home value growth in the year after winning football's biggest game In 13 of the past 20 years, the metro area that won the professional football championship saw home values grow faster than the U.S. average in the year that followed, according to the Zillow Home Value Index.On average, the typical home in a championship market gained $4,437 more than the typical U.S. home in the year after the win.SEATTLE, Feb. 3, 2026 /PRNewswire/ -- Football fans in Seattle and Boston know that winning the season's biggest game this weekend comes with bragging rights, a parade and gaudy championship rings. A new Zillow® analysis finds that home

    2/3/26 8:00:00 AM ET
    $Z
    $ZG
    Real Estate

    $ADPT
    $GRND
    $TRUP
    $VCSA
    SEC Filings

    View All

    Adaptive Biotechnologies Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Adaptive Biotechnologies Corp (0001478320) (Filer)

    2/5/26 4:15:24 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Adaptive Biotechnologies Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - Adaptive Biotechnologies Corp (0001478320) (Filer)

    1/12/26 8:15:41 AM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 8-K filed by Adaptive Biotechnologies Corporation

    8-K - Adaptive Biotechnologies Corp (0001478320) (Filer)

    12/30/25 8:00:14 AM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADPT
    $GRND
    $TRUP
    $VCSA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley resumed coverage on Adaptive Biotechnologies with a new price target

    Morgan Stanley resumed coverage of Adaptive Biotechnologies with a rating of Equal-Weight and set a new price target of $21.00

    12/2/25 8:23:20 AM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Guggenheim initiated coverage on Adaptive Biotechnologies with a new price target

    Guggenheim initiated coverage of Adaptive Biotechnologies with a rating of Buy and set a new price target of $20.00

    9/30/25 8:35:50 AM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Zillow C upgraded by Bernstein with a new price target

    Bernstein upgraded Zillow C from Mkt Perform to Outperform and set a new price target of $105.00

    9/17/25 7:54:13 AM ET
    $Z
    Real Estate

    $ADPT
    $GRND
    $TRUP
    $VCSA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Zage George Raymond Iii bought $675,500 worth of shares (50,000 units at $13.51), increasing direct ownership by 0.62% to 8,113,283 units (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    12/9/25 6:47:20 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Director Zage George Raymond Iii bought $2,091,000 worth of shares (155,000 units at $13.49), increasing direct ownership by 1% to 8,063,283 units (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    12/5/25 5:00:05 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Director Zage George Raymond Iii bought $2,651,000 worth of shares (200,000 units at $13.26), increasing direct ownership by 1% to 7,983,283 units (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    12/4/25 5:15:57 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    $ADPT
    $GRND
    $TRUP
    $VCSA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 5, 2021 - Coronavirus (COVID-19) Update: FDA Authorizes Adaptive Biotechnologies T-Detect COVID Test

    For Immediate Release: March 05, 2021 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the T-Detect COVID Test developed by Adaptive Biotechnologies. The T-Detect COVID Test is a next generation sequencing based (NGS) test to aid in identifying individuals with an adaptive T cell immune response to SARS-CoV-2, indicating recent or prior infection with SARS-CoV-2.  “Today’s authorization further und

    3/5/21 10:37:33 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADPT
    $GRND
    $TRUP
    $VCSA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Lu James Fu Bin sold $14,595,500 worth of shares (1,450,000 units at $10.07) (SEC Form 4)

    4 - Grindr Inc. (0001820144) (Issuer)

    2/6/26 7:50:44 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Chief Financial Officer Piskel Kyle exercised 2,145 shares at a strike of $12.14 and sold $39,597 worth of shares (2,145 units at $18.46) (SEC Form 4)

    4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)

    2/6/26 7:30:18 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Scientific Officer Robins Harlan S sold $799,105 worth of shares (42,788 units at $18.68), decreasing direct ownership by 4% to 1,179,524 units (SEC Form 4)

    4 - Adaptive Biotechnologies Corp (0001478320) (Issuer)

    2/4/26 7:48:48 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADPT
    $GRND
    $TRUP
    $VCSA
    Financials

    Live finance-specific insights

    View All

    Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results

    SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 was an outstanding year for Adaptive, marked by strong execution and meaningful progress across the business," said Chad Robins, chief executive officer and co-founder of Adaptive Biotechnologies. "We delivered 46% revenue growth and achieved profitability in our MRD business, while advancing our Immune Medici

    2/5/26 4:05:00 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Trupanion Announces Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

    SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 fourth quarter and full year after the market closes on Thursday, February 12, 2026. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. P

    1/22/26 4:16:00 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

    SEATTLE, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, February 5, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the "Investors" section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for repl

    1/22/26 4:05:00 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADPT
    $GRND
    $TRUP
    $VCSA
    Leadership Updates

    Live Leadership Updates

    View All

    Grindr Announces Leadership Appointments

    Tristan Pineiro Appointed Chief Marketing Officer; Zac Katz Named Chief Legal Officer Grindr Inc., the Global Gayborhood in Your Pocket™, today announced the appointment of Tristan Pineiro to Chief Marketing Officer and Zac Katz to Chief Legal Officer, General Counsel, and Head of Global Affairs, effective immediately. "These appointments reflect the scope and responsibility Zac and Tristan deliver on daily," said George Arison, CEO of Grindr. "They are distinctive leaders who consistently raise the bar on how we execute on our ambitious vision for Grindr." Pineiro has led a significant repositioning of Grindr's brand through the Global Gayborhood platform, strengthening cultural rele

    1/9/26 9:00:00 AM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    AUTOCANADA APPOINTS FADE BOURAS AS CHIEF OPERATING OFFICER AND JOHN NORTH TO ITS BOARD OF DIRECTORS

    EDMONTON, AB, Dec. 15, 2025 /CNW/ - AutoCanada Inc. ("AutoCanada" or the "Company") (TSX:ACQ), a leader in Canadian automotive retail, today announced the appointment of Fade Bouras as Chief Operating Officer, effective January 15, 2026. The Company also announced the appointment of John North to its Board of Directors, effective immediately. Appointment of Fade Bouras as Chief Operating Officer Mr. Bouras brings more than 22 years of automotive retail experience, having built his career across every major function within dealership operations. Most recently, he served as Chief Operating Officer of HGrégoire, where he led a large, high-volume, multi-location automotive retail platform and o

    12/15/25 6:25:00 PM ET
    $GRND
    $LAD
    $XPEL
    Computer Software: Programming Data Processing
    Technology
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Zillow launches messaging, a new way for home shoppers to collaborate within the Zillow app

    Messaging debuts in Zillow's Fall Launch, keeps home shoppers connected and in control at every step SEATTLE, Oct. 28, 2025 /PRNewswire/ -- Zillow® is introducing messaging, a new feature that lets buyers and their co-shopper chat, share listings and stay organized — all within the Zillow app. Home shopping often means buzzing phones, crowded browser tabs and decisions buried among memes. With Zillow's new messaging feature, every listing conversation stays organized in a single thread, reducing the app-hopping and missed messages that can slow a buyer's momentum. "This new messaging product brings the collaboration that already happens across text messages dir

    10/28/25 12:01:00 AM ET
    $Z
    $ZG
    Real Estate

    $ADPT
    $GRND
    $TRUP
    $VCSA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Grindr Inc.

    SC 13D/A - Grindr Inc. (0001820144) (Subject)

    12/9/24 5:32:00 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    Amendment: SEC Form SC 13D/A filed by Grindr Inc.

    SC 13D/A - Grindr Inc. (0001820144) (Subject)

    11/13/24 5:22:57 PM ET
    $GRND
    Computer Software: Programming Data Processing
    Technology

    SEC Form SC 13G filed by Adaptive Biotechnologies Corporation

    SC 13G - Adaptive Biotechnologies Corp (0001478320) (Subject)

    11/13/24 4:30:24 PM ET
    $ADPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care